These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29314424)

  • 1. The interaction of sex, height, and QRS duration on the effects of cardiac resynchronization therapy on morbidity and mortality: an individual-patient data meta-analysis.
    Linde C; Cleland JGF; Gold MR; Claude Daubert J; Tang ASL; Young JB; Sherfesee L; Abraham WT
    Eur J Heart Fail; 2018 Apr; 20(4):780-791. PubMed ID: 29314424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure.
    Cleland JG; Abraham WT; Linde C; Gold MR; Young JB; Claude Daubert J; Sherfesee L; Wells GA; Tang AS
    Eur Heart J; 2013 Dec; 34(46):3547-56. PubMed ID: 23900696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
    Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between sex, body size, and cardiac resynchronization therapy benefit: A patient-level meta-analysis of randomized controlled trials.
    Friedman DJ; Olivas-Martinez A; Dalgaard F; Fudim M; Abraham WT; Cleland JGF; Curtis AB; Gold MR; Kutyifa V; Linde C; Tang AS; Ali-Ahmed F; Inoue LYT; Sanders GD; Al-Khatib SM
    Heart Rhythm; 2024 Jun; 21(6):845-854. PubMed ID: 38360252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of cardiac resynchronization without a defibrillator on morbidity and mortality: an individual patient data meta-analysis of COMPANION and CARE-HF.
    Cleland JGF; Bristow MR; Freemantle N; Olshansky B; Gras D; Saxon L; Tavazzi L; Boehmer J; Ghio S; Feldman AM; Daubert JC; de Mets D
    Eur J Heart Fail; 2022 Jun; 24(6):1080-1090. PubMed ID: 35490339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of QRS Duration to Clinical Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients Without Left Bundle Branch Block: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy.
    Biton Y; Kutyifa V; Cygankiewicz I; Goldenberg I; Klein H; McNitt S; Polonsky B; Ruwald AC; Ruwald MH; Moss AJ; Zareba W
    Circ Heart Fail; 2016 Feb; 9(2):e002667. PubMed ID: 26823498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of QRS morphology and duration on outcomes after cardiac resynchronization therapy: Results from the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial (RAFT).
    Birnie DH; Ha A; Higginson L; Sidhu K; Green M; Philippon F; Thibault B; Wells G; Tang A
    Circ Heart Fail; 2013 Nov; 6(6):1190-8. PubMed ID: 23995437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac resynchronization therapy in women versus men: observational comparative effectiveness study from the National Cardiovascular Data Registry.
    Zusterzeel R; Spatz ES; Curtis JP; Sanders WE; Selzman KA; Piña IL; Bao H; Ponirakis A; Varosy PD; Masoudi FA; Caños DA; Strauss DG
    Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2 Suppl 1):S4-11. PubMed ID: 25714821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absolute survival after cardiac resynchronization therapy according to baseline QRS duration: a multinational 10-year experience: data from the Multicenter International CRT Study.
    Gasparini M; Leclercq C; Yu CM; Auricchio A; Steinberg JS; Lamp B; Klersy C; Leyva F
    Am Heart J; 2014 Feb; 167(2):203-209.e1. PubMed ID: 24439981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study.
    Gold MR; Thébault C; Linde C; Abraham WT; Gerritse B; Ghio S; St John Sutton M; Daubert JC
    Circulation; 2012 Aug; 126(7):822-9. PubMed ID: 22781424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart Size Difference Drives Sex-Specific Response to Cardiac Resynchronization Therapy: A Post Hoc Analysis of the MORE-MPP CRT Trial.
    Wijesuriya N; Mehta V; De Vere F; Howell S; Niederer SA; Burri H; Sperzel J; Calo L; Thibault B; Lin W; Lee K; Grammatico A; Varma N; Gwechenberger M; Leclercq C; Rinaldi CA
    J Am Heart Assoc; 2024 Jun; 13(12):e035279. PubMed ID: 38879456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patient-level data.
    Zusterzeel R; Selzman KA; Sanders WE; Caños DA; O'Callaghan KM; Carpenter JL; Piña IL; Strauss DG
    JAMA Intern Med; 2014 Aug; 174(8):1340-8. PubMed ID: 25090172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness of CRT on improvement of survival of heart failure patients in real life clinical settings.
    Hudak M; Kerekanic M; Misikova S; Komanova E; Boho A; Stancak B
    Acta Cardiol; 2017 Apr; 72(2):180-187. PubMed ID: 28597793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QRS axis and the benefit of cardiac resynchronization therapy in patients with mildly symptomatic heart failure enrolled in MADIT-CRT.
    Brenyo A; Rao M; Barsheshet A; Cannom D; Quesada A; McNitt S; Huang DT; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2013 Apr; 24(4):442-8. PubMed ID: 23252875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QRS frequency characteristics help predict response to cardiac resynchronization in left bundle branch block less than 150 milliseconds.
    Niebauer MJ; Rickard J; Polakof L; Tchou PJ; Varma N
    Heart Rhythm; 2014 Dec; 11(12):2183-9. PubMed ID: 25068573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cardiac resynchronization therapy on patients with heart failure and narrow QRS complexes: a meta-analysis of five randomized controlled trials.
    Wang G; Zhao Z; Zhao S; Ding S; Shen S; Wang L
    J Interv Card Electrophysiol; 2015 Oct; 44(1):71-9. PubMed ID: 26162538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Gender on Outcomes After Cardiac Resynchronization Therapy in Patients With a Narrow QRS Complex: A Subgroup Analysis of the EchoCRT Trial.
    Steffel J; Varma N; Robertson M; Singh JP; Bax JJ; Borer JS; Dickstein K; Ford I; Gorcsan J; Gras D; Krum H; Sogaard P; Holzmeister J; Brugada J; Abraham WT; Ruschitzka F
    Circ Arrhythm Electrophysiol; 2016 Jun; 9(6):. PubMed ID: 27282848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probability and magnitude of response to cardiac resynchronization therapy according to QRS duration and gender in nonischemic cardiomyopathy and LBBB.
    Varma N; Manne M; Nguyen D; He J; Niebauer M; Tchou P
    Heart Rhythm; 2014 Jul; 11(7):1139-47. PubMed ID: 24704570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac resynchronization therapy and QRS duration: systematic review, meta-analysis, and meta-regression.
    Kang SH; Oh IY; Kang DY; Cha MJ; Cho Y; Choi EK; Hahn S; Oh S
    J Korean Med Sci; 2015 Jan; 30(1):24-33. PubMed ID: 25552880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inverse Relationship of Blood Pressure to Long-Term Outcomes and Benefit of Cardiac Resynchronization Therapy in Patients With Mild Heart Failure: A Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Long-Term Follow-Up Substudy.
    Biton Y; Moss AJ; Kutyifa V; Mathias A; Sherazi S; Zareba W; McNitt S; Polonsky B; Barsheshet A; Brown MW; Goldenberg I
    Circ Heart Fail; 2015 Sep; 8(5):921-6. PubMed ID: 26179186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.